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Abstract 
Background:  Hemodynamic instability is frequent and outcome-relevant in critical illness. The understanding of 
complex hemodynamic disturbances and their monitoring and management plays an important role in treatment of 
intensive care patients. An increasing number of treatment recommendations and guidelines in intensive care medi-
cine emphasize hemodynamic goals, which go beyond the measurement of blood pressures. Yet, it is not known to 
which extent the infrastructural prerequisites for extended hemodynamic monitoring are given in intensive care units 
(ICUs) and how hemodynamic management is performed in clinical practice. Further, it is still unclear which factors 
trigger the use of extended hemodynamic monitoring.
Methods: In this multicenter, 1-day (November 7, 2013, and the preceding 24 h) cross-sectional study, we retrieved 
data on patient monitoring from ICUs in Germany, Austria, and Switzerland by means of a web-based case report 
form. One hundred and sixty-one intensive care units contributed detailed information on availability of hemody-
namic monitoring. In addition, detailed information on hemodynamic monitoring of 1789 patients that were treated 
on due date was collected, and independent factors triggering the use of extended hemodynamic monitoring were 
identified by multivariate analysis.
Results: Besides basic monitoring with electrocardiography (ECG), pulse oximetry, and blood pressure monitoring, 
the majority of patients received invasive arterial (77.9 %) and central venous catheterization (55.2 %). All over, addi-
tional extended hemodynamic monitoring for assessment of cardiac output was only performed in 12.3 % of patients, 
while echocardiographic examination was used in only 1.9 %. The strongest independent predictors for the use of 
extended hemodynamic monitoring of any kind were mechanical ventilation, the need for catecholamine therapy, 
and treatment backed by protocols. In 71.6 % of patients in whom extended hemodynamic monitoring was added 
during the study period, this extension led to changes in treatment.
Conclusions: Extended hemodynamic monitoring, which goes beyond the measurement of blood pressures, to 
date plays a minor role in the surveillance of critically ill patients in German, Austrian, and Swiss ICUs. This includes 
also consensus-based recommended diagnostic and monitoring applications, such as echocardiography and cardiac 
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Background
Cardiocirculatory dysfunction with subsequent hemo-
dynamic instability is a frequent and crucial symptom 
found in many medical conditions requiring intensive 
care therapy. Hemodynamic instability diminishes oxy-
gen supply to the end organs and is associated with an 
increased mortality rate [1]. Thus, hemodynamic man-
agement represents a cornerstone of intensive care ther-
apy and has therefore been addressed by an increasing 
number of guidelines and recommendations [1–4]. Pul-
monary artery catheterization, various forms of indicator 
dilution, arterial pulse wave analysis, and in particular the 
increasing availability of ultrasound technologies nowa-
days allow for closely monitor cardiocirculatory function. 
This comprises—besides blood pressures—the measure-
ment of blood flow, contractile function of the heart, and 
metabolic parameters giving information about oxygen 
demand and consumption. Though recently challenged 
with regard to an approach originally promoted by Rivers 
et al. [5] for patients with severe sepsis and septic shock, 
goal-directed strategies of hemodynamic management 
based on parameters of extended hemodynamic and 
metabolic monitoring are increasingly recommended in 
different national and international guidelines, in par-
ticular for peri- and postoperative care [6–10]. However, 
how hemodynamic monitoring is actually practiced in 
intensive care units (ICU) is only scarcely described. This 
comprises the question whether the tools and the infra-
structural resources, which are necessary for the routine 
use of extended hemodynamic monitoring, are available 
in all institutions. Further, it remains unclear which fac-
tors trigger the use of extended hemodynamic monitor-
ing in practice. So far, it is also not known whether and 
what kind of therapeutic consequences arise from the 
implementation of extended hemodynamic monitoring.
The purpose of this cross-sectional study was to char-
acterize how cardiovascular function is monitored in 
critically ill patients in three European countries (Ger-
many, Austria, and Switzerland). We further aimed to 
identify patient- or healthcare-related factors that trigger 
the use of advanced hemodynamic monitoring.
Methods
Study design
This cross-sectional study was initiated by the scientific 
working group “Intensive Care Medicine” of the German 
Society of Anaesthesiology and Intensive Care Medi-
cine (DGAI) and was endorsed by the Austrian Society 
for Anaesthesiology, Resuscitation, and Intensive Care 
Medicine (OGARI), the Swiss Society of Intensive Care 
Medicine (SGI), the German Society of Trauma Surgery 
(DGU), the German Interdisciplinary Association of 
Intensive Care and Emergency Medicine (DIVI), the Fed-
eration of Austrian Societies of Intensive Care Medicine 
(FASIM), and the European Society of Intensive Care 
Medicine (ESICM).
The ethics committees of the University Homburg/
Saar, Germany, reviewed and approved the study proto-
col (Ethik-Kommission der Ärztekammer des Saarlandes 
mit Kenn-Nr. Ha07/13). The need for written informed 
consent was waived since the research involved no risk 
to the patients, and patient data were anonymized before 
transmission to the database. We directly contacted mem-
bers of the aforementioned societies and associations via 
email or via the internet presentations of the societies and 
invited them to electronically register their ICUs for par-
ticipation in this study. Registered units were then pro-
vided with the detailed study protocol and were instructed 
how to approach approval from their local ethics commit-
tee. Registration for the study was only completed with the 
written approval of the respective local ethics committee.
Data collection
Data collection was performed via a web-based case 
report form (CRF). This CRF consisted of two parts. Part 
one gathered general information about the hospital, the 
respective ICU, the monitoring equipment available in that 
ICU, and implemented treatment strategies (treatment 
algorithms, standard operating procedures). Part two then 
enquired specific information about the hemodynamic 
monitoring and hemodynamic management strategy used 
in each individual patient treated in the respective unit on 
November 7, 2013, and the preceding 24 h.
Endpoints
We performed descriptive analyses of the participat-
ing medical centers and their ICUs. Then, we evalu-
ated the availability of technical equipment and related 
monitoring options. We further investigated whether 
standardized treatment plans (i.e., algorithms or stand-
ard operating procedures) were implemented for hemo-
dynamic management. Next, we analyzed whether the 
output monitoring. Mechanical ventilation, the use of catecholamines, and treatment backed by protocol could be 
identified as factors independently associated with higher use of extended hemodynamic monitoring.
Keywords: Hemodynamic management, Treatment protocol, Guidelines, Echocardiography, Thermodilution,  
Pulse contour analysis, Cardiac output, Pulse pressure variation, Stroke volume variation
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availability of the different monitoring options was asso-
ciated with hospital size, academic status of the hospital, 
the leading medical discipline in the ICU, or the fact that 
standardized treatment plans were implemented.
Furthermore, we characterized the patients that par-
ticipated with their data in this study. We analyzed the 
reasons for admission to the ICU, their leading diagno-
sis, and the severity of illness quantified by the simplified 
acute physiology score (SAPS) of the included patients 
in each participating ICU. We investigated how many 
patients required catecholamines or vasopressors. In 
order to determine how many patients qualified for the 
use of functional parameters of preload, such as pulse 
pressure or stroke volume variation, we characterized 
who was on mechanical ventilation and which kind of 
cardiac rhythm was present in those patients.
After descriptive analyses, we investigated by a multivar-
iate regression analysis which factors were independently 
associated with the choice of different monitoring modali-
ties. These factors comprised infrastructural (hospital size, 
academic affiliation, leading medical discipline, imple-
mented treatment protocols) or patient-associated (lead-
ing diagnosis, severity of illness, mechanical ventilation, 
need of catecholamine or vasopressor support) aspects.
Finally, we analyzed whether an escalation of cardio-
vascular monitoring within the last 24 h influenced treat-
ment strategies in the included patients.
Statistical analyses
Data analysis was performed using IBM SPSS Statistics 
for Windows, version 22.0 (IBM Corp., Armonk, NY, 
USA), and StatsDirect, version 2.7.9 (StatsDirect LTD, 
Cheshire, UK). All tests were conducted two-sided in 
an explorative manner on a 5  % significance level. For 
descriptive statistical analysis, we calculated absolute 
and relative frequencies (in percentage) to describe cat-
egorical data and mean ± standard deviation and median 
as well as range for continuous data. To identify factors 
independently associated with the use of extended hemo-
dynamic monitoring modalities, we performed multiple 
logistic regression models using a stepwise forward and 
backward variable selection approach. Based on these 
statistical models, odds ratio estimates (OR) were calcu-
lated with 95 % confidence intervals (CI). In the multiple 
regression analysis, we included all factors showing a p 
value of ≤0.05 in univariate analyses. For variable selec-
tion in multiple regression analysis, we considered a p 
value of 0.10 to indicate statistical significance.
Results
One hundred and sixty-one out of 165 initially registered 
ICUs contributed data regarding their infrastructure, 
their manning, the availability of monitoring equipment 
and monitoring standards, implemented treatment algo-
rithms and standard operating procedures, as well as 
data from 1798 patients to this study. After removal of 
nine incomplete questionnaires, data from 1789 patients 
remained for analysis.
Participating centers and their monitoring resources
Characteristics of the participating centers and their 
ICUs are given in Table  1. 60.0  % of the participating 
units were at university hospitals. Figure 1 illustrates the 
all-over availability of extended hemodynamic monitor-
ing, i.e., monitoring entities going beyond basic moni-
toring with electrocardiography (ECG), intermittent 
noninvasive blood pressure measurement, and pulse oxi-
metry. Echocardiography (transthoracic or transesopha-
geal) was available in 95.0  % and 85.7  %, and monitors 
using thermodilution (transpulmonary and pulmonary 
arterial) were available in 88.2 and 75.0 % of the partici-
pating units. In Table 2, those data are stratified accord-
ing to the unit-leading medical discipline. A stratification 
of those availabilities of extended hemodynamic moni-
toring according to the size of the hospital and if the 
unit was part of a university hospital is given in table a1 
(Additional file 1: Table a1).   
Table 1 Characterization of  the 161 participating centers 
and their intensive care units
n
Hospital size
≤500 beds 26 (16 %)
501–1000 beds 48 (30 %)
>1000 beds 87 (54 %)
University hospital 97 (60 %)
Non-university Hospital 64 (40 %)
Type of ward
ICU 114 (70.8 %)
IMC 12 (7.5 %)
Mixed 35 (21.7 %)
Infrastructure of ward
Number of beds/ward 14.7 ± 8.4 Median: 12 (4–64)
Number beds/physician 5.5 ± 2.6 Median: 5 (1.5–16)
Number of beds/nurse 2.4 ± 0.7 Median: 2.3 (0.8–7.2)
Algorithms implemented 118 (73.3 %)
Leading disciplines
Anaesthesia 76 (47.2 %)
Medical 14 (8.7 %)
Neurology 4 (2.5 %)
Surgery 12 (7.5 %)
Interdisciplinary 28 (17.4 %)
Cardiac surgery 18 (11.2 %)
Others 9 (5.6 %)
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Hemodynamic treatment standards
Figure a1 (Additional file 2: Figure a1) shows the propor-
tion of units which had implemented treatment protocols 
relevant for hemodynamic management. Protocols for 
treatment of sepsis were implemented in 70 % of all units, 
as well as “other guidelines” such as institutional standard 
operating procedures. Table 3 gives detailed information, 
which treatment protocols were implemented strati-
fied according to the unit-leading disciplines. In table a2 
(Additional file 3: Table a2), this information is stratified 
according to the size and kind of hospital.
Patient data
All together, we analyzed data of 1789 patients. Informa-
tion on the reason for ICU admission, if it was a sched-
uled admission, and information, to which kind of unit 
patients were admitted, are given in table a3 (see Addi-
tional file 4: Table a3). Accordingly, 50.0 % of admissions 
were postsurgery and 45.8 % were medical emergencies. 
Further, data on intensive care scoring as well as informa-
tion, if a hemodynamic treatment plan was used in the 
respective patient, are given. 48.9 % of the patients were 
mechanically ventilated, 39.2 % received catecholamines, 
and 58  % were treated based on a guideline or a treat-
ment protocol.
We also retrieved detailed information on the main 
diagnosis relevant for the treatment in the ICU. Accord-
ing to those main diagnoses, patients were stratified to 
four clusters: Cluster “surgery” included all patients with 
a surgical (except cardiac surgical) procedure immedi-
ately prior to admittance to the ICU (n = 690); the cluster 
“cardiac surgery” comprised all patients following car-
diac surgery procedures (n = 451); whereas in the clus-
ter “medical” all patients were included with a primarily 
medical diagnosis, in the cluster “neuro,” all patients were 
included with a primarily neurological diagnosis, which 
was not associated with a surgical procedure.
Cardiac surgery was analyzed separately from surgi-
cal patients, since cardiovascular treatment in the ICU 
in this group is in particular determined by the conse-
quences of intraoperative myocardial ischemia and rep-
erfusion and the use of extracorporeal circulation.
Fig. 1 Availability of extended monitoring modalities. This figure 
depicts the different extended monitoring modalities and the 
percentages of units which have those available at the bedside (IPM 
invasive pressure monitoring, PPV pulse pressure variation, VC volume 
clamp, TTE transthoracic echocardiography, TEE transesophageal 
echocardiography, APCA autocalibrated pulse contour analysis, ScvO2 
central venous oxygen saturation, TTD transpulmonary thermodilu-
tion, PATD pulmonary artery thermodilution)
Table 2 Available monitoring modalities stratified to unit-leading medical discipline
Anaesthesia Surgery Cardiac surgery Medical Neurology Interdisciplinary Others
n = 76 (%) n = 12 (%) n = 17 (%) n = 14 (%) n = 4 (%) n = 28 (%) n = 9 (%)
Invasive pressure monitoring
Invasive pressure monitoring 100 100 100 100 100 100 100
Automated PPV 39.5 41.7 41.2 42.9 50 35.7 22.2
Semi-invasive extended monitoring
Finger plethysmography 7.9 8.3 5.9 7.1 25 7.1 0
Bioimpedance 1.3 0 0 0 0 3.6 0
Esophageal Doppler 10.5 8.3 5.9 7.1 0 17.9 11.1
Echocardiography
Transthoracic 96.1 91.7 100 100 75 92.9 88.9
Transesophageal 90.8 58.3 94.1 100 50 75 88.9
Semi-invasive extended monitoring
Autocalibrated pulse contour analysis 51.3 25 43.8 35.7 0 21.4 55.6
Continuous ScvO2 28.9 33.3 37.5 35.7 0 25 55.6
Invasive extended hemodynamic monitoring
Transpulmonary thermodilution 96.1 75 81.3 92.9 75 82.1 88.9
Transpulmonary lithium dilution 6.6 0 0 7.1 0 3.6 0
Pulmonary artery thermodilution 80.3 58.3 100 92.9 25 53.6 77.8
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Practice of hemodynamic monitoring
Basic hemodynamic monitoring: In nearly all patients, 
basic hemodynamic monitoring, i.e., continuous ECG 
(n =  1753; 97.7  %), pulse oximetry (n =  1767; 98.4  %), 
and blood pressure monitoring, was performed. The 
latter was performed either noninvasively with a blood 
pressure cuff (n = 581; 32.5 %) or invasively (n = 1393; 
77.9 %).
Extended hemodynamic monitoring: Fig.  2a depicts 
which kind of extended hemodynamic monitoring was 
actually used in the ICUs. In Fig. 2b, this information is 
stratified per primary diagnosis. Table 4 then lists which 
forms of extended hemodynamic monitoring were per-
formed in the studied patients, again stratified to clusters 
of primary diagnosis.
Figure  3 plots the associations and their strengths 
between specific infrastructural and patient characteris-
tics as factors independently associated with to the use of 
extended hemodynamic monitoring, which we retrieved 
by multivariate regression analysis. The use of catecho-
lamines (OR 2.87 (CI 2.2–3.75)], treatment backed on 
protocols [OR 2.31 (CI 1.78–3.0)], and mechanical venti-
lation [OR 1.57 (CI 1.20–2.04)] were the strongest factors 
positively associated with the use of extended hemody-
namic monitoring. Further positive predictors were a 
primarily medical [OR 1.85 (CI 1.16–2.95)] or cardiac 
surgical [OR 2.23 (CI 1.33–3.75)] diagnosis, and the lead-
ing medical discipline being medicine or neurology [OR 
2.64 (CI 1.81–3.86)].
Changes in hemodynamic monitoring and resulting 
therapeutic consequences
The addition of one or more hemodynamic monitoring 
tools during the last 24  h was reported in 116 patients. 
This was in 54 (46.6 %) patients the implementation of an 
arterial catheter, in 35 (30.2 %) patients the implementa-
tion of a central venous catheter, in 34 (29.3 %) patients 
the performance of one or multiple echocardiographic 
examinations (either transthoracic or transesopha-
geal), in 22 (19.0  %) patients the implementation of 
transpulmonary thermodilution, in 8 (6.9  %) patients 
the insertion of a pulmonary artery catheter, in 4 (3.5 %) 
patients the implementation of autocalibrated pulse con-
tour analysis, and in 22 (19.0 %) patients the addition of 
other monitoring techniques. In 83 of the 116 patients, 
direct therapeutic consequences (71.6 %) because of this 
monitoring escalation were reported.
Discussion
The results of this cross-sectional study reflect how 
hemodynamic monitoring is performed in reality in 
ICUs in the three European countries Germany, Austria, 











Interdisciplinary n = 28 (%) Others
n = 9 (%)
Septic shock 67.1 83.3 64.7 64.3 75 82.1 55.6
Cardiac surgery 25 33.3 76.5 7.1 0 14.3 44.4
Neurosurgery 35.5 58.3 5.9 0 50 17.9 33.3
Trauma 56.6 75 5.9 0 25 42.9 44.4
Myocardial infarction 32.9 25 35.3 57.1 25 39.3 11.1
Others 13.2 25 11.8 28.6 25 21.4 11.1
Fig. 2 Use of extended hemodynamic monitoring. a The degree 
of use of measuring extended hemodynamic monitoring divided 
into the three subdomains: cardiac output, preload parameters, and 
microcirculation. b The degree of extended hemodynamic monitor-
ing in general clustered by primary diagnosis
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Table 4 Implemented extended monitoring clustered per  primary diagnosis and  need for  treatment with  vasoactive 
agents or mechanical ventilation
Implemented monitoring Primary diagnosis Vasoactive agents Mechanical ventilation
Medical Neuro Surgery Cardiac surgery
n = 504 (%) n = 144 (%) n = 690 (%) n = 451 (%) n = 702 (%) n = 874 (%)
Basic 96.2 98.6 97.8 99.1 98.9 99.3
Basic plus central venous  
and/or arterial line
85.3 79.2 85.2 94.2 98.6 96.1
Extended 38.5 24.3 21.7 38.4 45.3 39.6
Cardiac output 12.3 4.2 10.3 17.8 24.2 20.8
 Pressure-based preload parameters 44.4 37.5 51.6 79.2 74.4 69.5
 Volumetric preload parameters 17.5 4.2 9.3 13.1 21.3 17.3
 Dynamic preload parameters 9.3 5.5 9.7 7.3 16.5 14.9
 Microcirculation 3.2 0.7 0.3 3.6 3.8 3.2
Fig. 3 Independent factors to the use of extended hemodynamic monitoring. This figure plots the strengths of associations between specific 
infrastructural and patient characteristics as independent factors to the use of extended hemodynamic monitoring. Items marked in gray served as 
the respective reference categories
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and Switzerland. In fact, all patients were monitored 
with basic hemodynamic monitoring consisting of ECG, 
blood pressure measurements, and pulse oximetry. Also 
the majority of patients received invasive arterial and 
central venous catheterization. Extended hemodynamic 
monitoring, and in particular monitoring of cardiac out-
put, although widely available, was performed all over in 
less than 15 %. Mechanical ventilation, treatment backed 
by protocols, and the need for catecholamine therapy 
were the factors independently associated with the use 
of advanced hemodynamic monitoring. This was also 
validated in subgroup analyses of patients treated by 
mechanical ventilation or vasoactive agents. The most 
frequently used method for preload monitoring was the 
assessment of filling pressures. The use of volumetric or 
dynamic parameters of preload was rare. In 71.6  % of 
patients, in whom extended hemodynamic monitoring 
was added during the study period, this addition of moni-
toring led to direct changes in treatment. The vast major-
ity of ICUs reported that protocols for hemodynamic 
treatment were available, and in nearly 60 % of patients, 
hemodynamic management was reported to be per-
formed according to an implemented treatment protocol. 
In particular, treatment protocols for patients with sep-
sis were established. Whether quality of cardiovascular 
treatment was influenced by the use of specific treatment 
protocols cannot be assessed on the basis of the present 
data.
The acknowledgement that hemodynamic instability 
influences morbidity and mortality of critically ill patients 
has led to the development of various techniques of 
advanced hemodynamic monitoring and cardiovascular 
imaging. Further, many technical approaches have been 
taken to measure even complex physiological signals with 
low or even no invasiveness in order to reduce the moni-
toring-associated risks [11]. Finally, guidelines, treatment 
protocols, and consensus-based recommendations for 
several major diagnoses relevant for intensive care treat-
ment have been developed in order to secure the transfer 
of best practice of hemodynamic management based on 
pathophysiological rationale and scientific evidence. But 
how this has influenced practice of hemodynamic moni-
toring and management in reality has only scarcely been 
investigated. Data regarding availability of monitoring 
equipment based on smaller surveys were published ear-
lier from Switzerland including 55 medical and surgical 
ICUs, from Germany in 55 cardiac surgery ICUs, as well 
as from Italy again in 71 cardiac surgery centers [12–14]. 
Strength of our data set is that it represents data from a 
broad spectrum of ICUs of different sizes and a balanced 
proportion of ICUs at both university hospitals and non-
university hospitals. This allows a comparison between 
different disciplines and institutions. Furthermore, we 
collected not only data on general availability of monitor-
ing equipment but also real patient data, showing which 
monitoring was actually used. This, in combination with 
a high number of patients included, allowed further iden-
tification of factors that independently triggered the use 
of extended hemodynamic monitoring.
Our data show that technical requirements for basic 
hemodynamic monitoring, i.e., ECG, noninvasive blood 
pressure monitoring, and pulse oximetry, were given on 
all units. Noninvasive, extended hemodynamic moni-
toring (finger plethysmography waveform analysis, con-
tinuous blood pressure monitoring by volume clamp 
methods, or esophageal Doppler) was only available in 
very few of the studied ICUs, which is in line with ear-
lier data from Switzerland [12]. Of note, there was obvi-
ously no relevant difference between the unit-leading 
disciplines regarding availability of these noninvasive 
technologies. Whether this low availability was caused by 
missing confidence in monitoring accuracy or by other 
reasons (for example economic) was beyond the scope of 
the present study.
In contrast, availability of echocardiography was much 
higher. Transthoracic echocardiography was available in 
more than 90  % of all units, with no major differences 
between different sizes of hospitals, between univer-
sity hospitals and non-university hospitals, or between 
the different unit-leading disciplines. Obviously, today 
also transesophageal echocardiography is widely avail-
able (i.e., in more than 80 % of the units). This underlines 
the high acceptance and appreciation of this technology 
in intensive care medicine also outside cardiac surgery 
[13, 14]. But this high availability and the strong recom-
mendations for its use [4, 15] are in contrast to the very 
low number of patients (34 out of 1790 patients, i.e., 
1.9  %) that were actually reported to be investigated by 
echocardiography during the 24-h study period. Inter-
estingly, Boulain et  al. demonstrated comparable num-
bers specifically regarding the use of echocardiography 
for hemodynamic management of shock [16]. Further, 
echocardiography is only scarcely used in practice in 
Europe for guiding fluid therapy as Cecconi et al. recently 
showed [17].
We defined semi-invasive extended hemodynamic 
monitoring as monitoring modalities which use either 
peripheral arterial or central venous vascular access for 
further analyses besides pressure monitoring (i.e., auto-
calibrated arterial pulse contour analysis) or continuous 
central venous oximetry. It is of interest that, although 
nearly all of the investigated patients had arterial and 
central venous catheters in place, these monitoring 
modalities were only available in the minority of units.
Invasive extended hemodynamic monitoring based on 
thermodilution was widely available. Besides in cardiac 
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surgery, which seems to remain a leading domain of the 
pulmonary artery catheter, the most frequent technology 
was transpulmonary thermodilution. However, the actual 
all-over use of both monitoring modalities is comparably 
low, as reflected in table a1 (Additional file 1: Table a1). 
This low use is supported also by the recent data from 
French ICUs, which points out the divergence between 
subjective perception of higher use reflected in the 
results of surveys among ICU physicians and the objec-
tive assessment based on patient data [12–14, 16].
Adequate monitoring and management of cardiac 
preload, and in particular the inaccuracy of the cardiac 
filling pressures CVP and PAOP as the rationale for guid-
ing fluid therapy, have recently led many scientific dis-
cussions. Although filling pressures can offer additional 
and relevant physiological information, current consen-
sus statements based on recently published data recom-
mend not to manage fluid therapy primarily by filling 
pressures [1, 18]. From that perspective, it is interest-
ing that still filling pressures were the main tool for the 
assessment of preload, whereas volumetric or functional 
parameters of preload played only a minimal role. This is 
again in line with the French findings of Boulaint et al. in 
patients with septic shock [16] and also with a recently 
published French study by Preau et  al. investigating the 
use of static and dynamic hemodynamic parameters for 
predicting fluid responsiveness prior to volume expan-
sion [19]. One explanation may be the frequently stressed 
limitations for the use of automated functional param-
eters of preload, i.e., the necessity of controlled mechani-
cal ventilation and the absence of significant arrhythmias. 
This can be partly substantiated by our data. Although 
more than 80 % of all patients presented with a cardiac 
rhythm that allowed interpretation of those parameters 
(sinus rhythm, pacer rhythms), only 22.9  % of patients 
were on fully controlled mechanical ventilation. In con-
trast, in the group of hemodynamic unstable patients that 
received vasoactive agents, though the rate of arrhyth-
mias was comparable, a higher ratio of 30.9  % fulfilled 
criteria for the assessment of functional preload param-
eters due to more frequent controlled mechanical venti-
lation. But even in this group, only about every second of 
these patients that fulfilled the criteria was monitored by 
dynamic preload parameters. Furthermore, thinking of 
the other two-thirds not fulfilling the criteria, it stresses 
the need for further development of functional parame-
ters of preload that operate independently from the pres-
ence of ventilation mode. This is important as one can 
argue that those patients reflected presumably the group 
of patients with the highest need for differentiated car-
diovascular management, because of the severity of their 
disease.
In particular, it is remarkable that the over-all fraction 
of patients monitored with cardiac output monitoring 
was as low as reported in 2003, i.e., more than 10 years 
ago, by Oldner et al. from 114 patients on Scandinavian 
ICUs [20]. Although in cardiac surgery patients and in 
patients receiving vasoactive agents, serving as a sign of 
hemodynamic instability, the proportion of patients in 
which cardiac output was monitored was now with 24 % 
slightly higher, the availability of novel and less invasive 
modalities for cardiac output monitoring has not exten-
sively increased the use of this parameter so far. It is fur-
ther remarkable that also the affiliation to a university 
hospital compared with a non-university hospital was no 
independent predictor for the use of extended hemody-
namic monitoring.
The present study has limitations given by the fact that 
it was a point prevalence study, and should therefore be 
primarily understood as an initial assessment of status 
quo of hemodynamic monitoring and management. Fur-
ther, inter- and intrapersonal reliability of the online CRF 
was not tested. Also the absence of more detailed back-
ground information on the specific hemodynamic proto-
cols used in each individual institution, and the lacking 
information of clinical outcome limits further conclu-
sions. Furthermore, the non-implementation of a stand-
ardized protocol cannot be automatically equated with 
the absence of knowledge on current guidelines or lower 
quality of patient care. However, treatment protocols 
were identified as one of the independent factors trigger-
ing the use of extended hemodynamic monitoring. Thus, 
they might moreover serve as an additional trigger for a 
closer hemodynamic evaluation in particular groups of 
patients. Here, further studies are desirable.
Conclusion
The results of this study draw a representative picture, 
how hemodynamic monitoring and management is per-
formed in intensive care medicine, and which factors 
independently favoured/refrained its use in three Euro-
pean countries. The study helped to reveal that extended 
hemodynamic monitoring, although available in most 
units, is applied only in a minor part for the surveillance 
of critically ill patients. Surprisingly, this included also 
consensus-based recommended diagnostic and moni-
toring applications, such as echocardiography and car-
diac output monitoring. In the majority of patients, in 
which monitoring was extended, this escalation resulted 
in changes in treatment. The use of catecholamines, 
mechanical ventilation, and treatment on the basis of a 
protocol were independently associated with the use 
of extended hemodynamic monitoring. On the oppo-
site, surgical patients were less exposed to extended 
Page 9 of 10Funcke et al. Ann. Intensive Care  (2016) 6:49 
hemodynamic monitoring compared with medical 
and cardiac surgery patients. The vast majority of ICUs 
reported that patients’ hemodynamic management was 
performed according to treatment protocols, in particu-
lar for sepsis.
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